O2matic

What O2matic does

O2matic ApS is a privately held Danish medical device company founded in Copenhagen in 2017 and headquartered in Herlev, Denmark. The company develops closed-loop autonomous oxygen titration systems that continuously measure patient SpO2 via pulse oximetry and automatically adjust oxygen flow to maintain clinician-set target saturation ranges, replacing manual dose titration.

Its product platform comprises two CE-marked devices built on the same proprietary algorithm: O2matic PRO, for hospital and acute care settings (ward, ED, ICU, step-down, rehabilitation), and O2matic HOT, positioned as the first CE-marked automated system for home oxygen therapy in COPD and chronic hypoxemic patients. A ruggedized military variant of PRO (IP54-rated, -20 to 50°C, 0–5,000 m altitude) extends the platform into prehospital, MEDEVAC, and field-hospital scenarios. O2matic Connectivity, a Microsoft Azure-hosted platform with HL7-based data streaming, supports remote clinician monitoring for home care.

O2matic PRO is certified as a Class IIB device under EU MDR by TÜV SÜD since 2019 and is manufactured under ISO 13485. Clinical validation rests on 11 peer-reviewed studies covering more than 300 patients. Revenue is generated primarily through medical device hardware sales (PRO and HOT) to hospitals and home-care providers in Europe, supplemented by a recurring software/connectivity layer for HOT. The company pursues a dual-use go-to-market, selling to civilian healthcare systems while engaging NATO and Danish defense procurement channels via Defense Tech Denmark, and is participating in the DoD-funded AURORA prehospital study led by the University of Colorado Anschutz while awaiting US market clearance.

Name

O2matic

Legal name

O2matic ApS

Website

https://o2matic.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

O2matic ApS is a Danish medical device company that develops CE-marked closed-loop systems (O2matic PRO and HOT) that automatically titrate oxygen flow based on continuous pulse oximetry, serving hospitals, home-care patients, and military prehospital providers.

Ownership category

akta.pro rank

Product category

Automated Oxygen Therapy Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC) (HLAHAGAD)

akta.pro secondary industries

Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD), Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM), Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate) (HLAHAGAI)

Keywords

• Automated oxygen therapy
• Closed-loop oxygen titration
• Medical oxygen devices
• Hospital respiratory equipment
• Home oxygen therapy systems

Headquarters

HQ city

Herlev

HQ country

Denmark

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical device hardware sales: Sale of O2matic PRO (hospital) and O2matic HOT (home) closed-loop oxygen titration devices as medical equipment. CE marked class IIB medical device certified by TÜV SÜD under EU MDR. Manufactured under ISO 13485. Service life of 5 years.
2. Software/subscription services: O2matic Connectivity platform for remote clinician monitoring and data streaming via Azure/HL7. Session data flows securely to clinical teams for early deterioration detection in home care settings.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

O2matic develops and sells CE-marked closed-loop automated oxygen therapy medical devices that continuously measure patient SpO2 via pulse oximetry and automatically titrate oxygen flow to keep patients within a clinician-set target range. Its two core products — O2matic PRO for hospital acute care and O2matic HOT for home oxygen therapy — are supported by the O2matic Connectivity remote-monitoring platform and validated by 11 peer-reviewed studies covering more than 300 patients.

Product overview

O2matic offers two CE-marked automated oxygen therapy products built on a single closed-loop titration platform. O2matic PRO serves hospital and acute care settings, automatically adjusting oxygen flow based on continuous SpO₂ monitoring. O2matic HOT extends the same autonomous titration technology to the home care setting, connecting to existing oxygen sources and streaming treatment data to clinicians. A military dual-use variant of PRO is under development for prehospital and combat environments. Both products use a proprietary algorithm to keep patients within target SpO₂ ranges, outperforming manual titration and fixed-dose approaches, and are supported by 11 peer-reviewed clinical studies covering more than 300 patients.

Differentiator

Problem solved

Functional benefit

Brands

• O2matic PRO: Automatic oxygen therapy device for hospital care - a closed-loop system that continuously measures SpO2 and titrates oxygen flow to keep patients within target range.
• O2matic HOT

Products and services

• O2matic PRO A closed-loop automatic oxygen therapy system for hospital and acute care settings. It continuously measures patient SpO2 via pulse oximetry and automatically titrates oxygen flow to keep each patient within the clinician-set target range, alerting staff only when clinical intervention is required. CE marked Class IIB under EU MDR, manufactured under ISO 13485, with a 5-year service life.
• O2matic HOT The first and only CE-marked automatic home oxygen therapy system. It connects to the patient's existing oxygen source, continuously adjusts oxygen flow based on blood oxygen levels, and streams session data to the clinical team via the O2matic Connectivity platform for remote monitoring and early deterioration detection. Targets COPD and chronic hypoxemic patients on long-term oxygen therapy.
• O2matic PRO Dual-Use / Military Variant A ruggedized adaptation of the O2matic PRO platform designed for military and prehospital deployments, including ground evacuation, MEDEVAC/HEMS, field hospital Role 1-3, and disaster/mass-casualty response. Features IP54-rated housing, extended operating temperature range (-20 to 50°C), altitude capability up to 5,000 m, and 90-minute battery time. Commercial in Europe; awaiting US market clearance.

Quantifiable outcome

• 85% time in target SpO2 range vs 47% with manual titration (PRO)
• +5 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• University of Colorado Anschutz School of MedicinecoreStrategic or Co-development Partner · 1 December 2025Leading the AURORA Project, a DoD-funded prehospital study evaluating O2matic's autonomous oxygen titration system in U.S. emergency care settings. Study aims to improve oxygen delivery in prehospital emergency care, focusing on resource conservation and survival outcomes.
• Defense Tech DenmarkminorStrategic or Co-development PartnerO2matic is part of Defense Tech Denmark organization supporting Danish defense technology companies and their engagement with military and NATO procurement.
• 4 US Level-1 Trauma CenterscoreStrategic or Co-development PartnerSAVE-O2 AI Project validating O2matic at four level-1-trauma centers and their ICUs in the US. Multi-center study of 300 critically ill patients evaluating if automated oxygen delivery consistently outperforms manual control across trauma, burn, and acute respiratory illness.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• ResMed: ResMed is a global leader in sleep-disordered breathing, COPD, and home oxygen therapy devices. Its connected health platform (AirView/myAir) parallels O2matic Connectivity, and its commercial reach into home care providers and DME channels makes it a strategically relevant competitor for the O2matic HOT home segment.
• Dräger: Dräger is a major European medical and safety technology company with a substantial anesthesia, ventilation, and patient monitoring portfolio. As a fellow European-based respiratory care vendor with established ICU and hospital sales channels, it is a natural regional incumbent competing for the same hospital procurement budgets as O2matic PRO.
• Philips Respironics: Philips Respironics is a dominant player in hospital and home oxygen therapy, CPAP/BiPAP, and ventilators. Its broad installed base in hospitals and home care providers represents both the competitive threat O2matic faces and the channel through which O2matic's PRO and HOT products could be distributed or displaced.
• Masimo: Masimo is a global leader in pulse oximetry and patient monitoring, the core sensing modality O2matic uses for closed-loop titration. While Masimo's SET pulse oximetry platform underpins much of the world's SpO2 monitoring, the company also has the R&D depth to develop or acquire closed-loop oxygen control, making it the most strategically consequential competitor and potential acquirer.
• Hamilton Medical: Hamilton Medical manufactures mechanical ventilators and intelligent ventilation modes used in ICUs worldwide. Several of Hamilton's adaptive support ventilation (ASV) features perform a closed-loop function analogous to O2matic's automated oxygen titration, making it a direct adjacent competitor in automated respiratory care for critically ill patients.

Direct peers

• Caire (Chart Industries): Caire, a Chart Industries company, manufactures stationary and portable oxygen concentrators and liquid oxygen systems for home and clinical long-term oxygen therapy. It is a direct peer in the home and hospital oxygen delivery category that O2matic HOT and PRO target.
• Maxtec (ICU Medical): Maxtec, now part of ICU Medical, specializes in oxygen blenders, air-oxygen mixers, and pulse oximetry sensors used in respiratory care. Its oxygen-air mixing and monitoring components overlap functionally with O2matic's titration platform, making it a direct peer in the oxygen delivery hardware category.
• Inogen: Inogen is a leading manufacturer of portable oxygen concentrators for the home and ambulatory long-term oxygen therapy market. O2matic HOT directly competes in the home oxygen delivery category with a closed-loop titration approach that contrasts with Inogen's fixed-dose portable concentrator model.

Emerging players

• Vapotherm: Vapotherm develops high velocity nasal insufflation (HVNI) systems for respiratory distress in hospital and prehospital settings. Its focus on non-invasive oxygen delivery and emerging role in prehospital and emergency care overlaps with O2matic's PRO and dual-use military positioning.

Regional players

• Weinmann Emergency: Weinmann Emergency (part of Löwenstein Medical) is a German manufacturer of emergency and transport ventilation, oxygen therapy, and monitoring devices. Its prehospital and emergency product portfolio overlaps directly with O2matic's dual-use military/EMS use cases and it is a strong regional peer in DACH and broader European markets.

Market position

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

• Xx.com/o2matic
• LinkedInlinkedin.com/company/o2matic-aps

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about O2matic